S.C. Johnson lands in No. 2 spot in Information Week 500 list ( Racine Wis.

S.C. Johnson lands in No. 2 spot in Information Week 500 list

Racine, Wis. - S.C. Johnson & Son Inc. made the No. 2 spot in the Information Week 500, up from 95^th place in 2004. The top spot in this year's list of technology innovators went to Capital One.

Seven other Wisconsin organzations, other than S.C. Johnson, made this year's list.
......

Full article >>>

Source:wistechnology.com By Eric Kleefeld 09/21/05

Page: 1 2
Related biology technology :

1. Johnson Controls deals for asset-tracking software
2. Johnson Controls adds renewable energy unit
3. Johnson Controls unit lands contract for plug-in hybrid battery
4. Johnson Controls to expand in Europe
5. Johnson Controls partners on car satellite linkup
6. Florida schools employ Johnson Controls technology to stop sex predators
7. Johnson Controls partnership wins new contract
8. Johnson Controls appoints Roell to head EOC
9. Johnson Controls reports record quarterly sales
10. SC Johnson issues trademark warning over web offer
11. Research park adds Johnson Controls, Eaton

Post Your Comments:

(Date:7/24/2014)... Calif. , July 24, 2014 SRI ... contract with the National Institute of Allergy and Infectious ... to conduct preclinical development of potential therapies for HIV ... drugs to treat HIV and AIDS and the complications ... as microbicides for preventing sexual transmission of HIV. ...

(Date:7/24/2014)... 24, 2014 WIRB-Copernicus Group ® ... ethical review services for clinical research, announced today ... division of Richmond, VA -based ... and biosecurity consulting firm in the ... biosafety division – WCG Biosafety™ – will be ...

(Date:7/24/2014)... 24, 2014 Cypher Genomics, Inc., ... of Adam Simpson as president and ... and comprehensive annotation and interpretation of individual human ... "Cypher,s technology has the potential to play ... diagnostic accuracy, optimizing therapeutic approaches and reducing adverse ...

(Date:7/23/2014)... Inc. (NASDAQ: SGMO ) today reported its ... For the second quarter ended June 30, 2014, ... or $0.10 per share, compared to a net loss ... same period in 2013. As of June 30, 2014, ... interest receivable of $236.7 million. Revenues for ...

[0] National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS [0] WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division [0] Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology [0] Sangamo BioSciences Reports Second Quarter 2014 Financial Results

... Submission for Removal of Clinical Hold, BERKELEY ... Board: GNTA) announced that the Company has,received notice ... European,Patent Office for its pipeline product, tesetaxel, a ... matter for the tesetaxel drug,substance and to processes ...

... prion reduction technology to, further reduce risk of variant ... ... Octaplas(R), - Octapharma sponsoring lunchtime Symposium at meeting to discuss ... product quality., MONTREAL, Canada and CAMBRIDGE, United Kingdom, June 10,/PRNewswire-FirstCall/ ...

... Targets, COPENHAGEN, June 10 Nuevolution A/S ... (Nasdaq: LXRX ) aimed,at the discovery of ... targets., Under the terms of the alliance, ... to identify novel small molecule,lead compounds against a ...

Cached Biology Technology:Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 2 Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 3 Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 4 ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China 2 ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China 3 ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China 4 ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China 5 ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China 6 Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals 2 Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals 3

Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals

(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...

(Date:7/24/2014)... on different species of fish, according to a ... Exeter which tested fish anti-predator behaviour. , ... predator model when exposed to additional noise, whereas ... , Lead author Dr Irene Voellmy of Bristol,s ... many aquatic environments have increased substantially during the ...

(Date:7/24/2014)... its own microbial terroir, meaning the microbial populations found ... the product, creating the final flavor according to research ... and Environmental Microbiology . This is the first time ... brewery. , Many sake makers inoculate with both ... of the University of California, Davis, but he and ...

Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2 Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3 Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4 The microbes make the sake brewery 2

[0] Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN [0] Noise pollution impacts fish species differently [0] The microbes make the sake brewery

... 2010) -- Drug delivery inside the body is a ... solutions, lipid membranes, and barriers between the blood and ... Institute of Physics publication the Journal of Chemical ... the hydration free energy (HFE) of a wide variety ...

... (July 27, 2010) -- In biology and genetics, the concept ... more (or less) than the sum of its parts. The ... an organism has the potential to depend strongly upon the ... even other mutations co-occurring in that gene. These genetic interactions, ...

... punch tiny holes in the protective membranes of cells, ... small molecules, proteins and DNA directly into living cells. ... light trigger the tiny blasts, which open holes in ... contained in the surrounding fluid. By adjusting laser ...

Cached Biology News:Getting a step ahead of pathogens 2 Nanoblasts from laser-activated nanoparticles move molecules, proteins and DNA into cells 2 Nanoblasts from laser-activated nanoparticles move molecules, proteins and DNA into cells 3 Nanoblasts from laser-activated nanoparticles move molecules, proteins and DNA into cells 4

Where do the drugs go?Getting a step ahead of pathogens Nanoblasts from laser-activated nanoparticles move molecules, proteins and DNA into cells

Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....

Rabbit polyclonal to FLIP ( Abpromise for all tested applications). entrezGeneID: 8837 SwissProtID: O15519...

... [EP282Y] to Asparagine synthetase ( ... applications). Antigen: ... residues in the C-terminus of ... Entrez GeneID: 440 ...

Fluorescein isothiocyanate (FITC) mouse anti-human IFN-alpha2 25 tests...

Biology Products:

Mouse Anti-Secretory Component Glycoprotein Monoclonal Antibody, Unconjugated, Clone SPM217 from Abcam Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam Mouse Anti-IFN-alpha2 Monoclonal Antibody, Fluorescein isothiocyanate (FITC) Conjugated, Clone 225.C from eBioscience